HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LncRNA MIAT regulated by selenium and T-2 toxin increases NF-κB-p65 activation, promoting the progress of Kashin-Beck Disease.

Abstract
LncRNA myocardial infarction associated transcript (MIAT) has been shown to be involved in osteoarthritis (OA), but its role in Kashin-Beck Disease (KBD) has rarely been reported. In this study, rats were administered with low selenium and/or T-2 toxin for 4 weeks to establish a KBD animal model. The serum selenium level, TNF-α and IL-1β contents, phosphorylated p65 (p-p65) and MIAT expression were increased in each intervention group. Next, we isolated the primary epiphyseal chondrocytes, and found that selenium treatment reversed the effects of T-2 toxin on chondrocyte injury, p-p65 and MIAT expression. In addition, MIAT overexpression or T-2 toxin treatment led to increased cell death, apoptosis, inflammation, NF-κB-p65 pathway activation and MIAT expression, which was rescued by selenium treatment or MIAT siRNA transfection. Our results suggested that lncRNA MIAT regulated by selenium and T-2 toxin increased the activation of NF-κB-p65, thus being involved in the progress of KBD.
AuthorsMin Shi, Ying He, Ying Zhang, Xiaobo Guo, Jing Lin, Wei Wang, Jinghong Chen
JournalHuman & experimental toxicology (Hum Exp Toxicol) Vol. 40 Issue 5 Pg. 869-881 (May 2021) ISSN: 1477-0903 [Electronic] England
PMID33233966 (Publication Type: Journal Article, Retracted Publication)
Chemical References
  • Interleukin-1beta
  • NF-kappa B
  • RNA, Long Noncoding
  • Tumor Necrosis Factor-alpha
  • Selenium
  • T-2 Toxin
Topics
  • Animals
  • Disease Models, Animal
  • Humans
  • Interleukin-1beta (drug effects)
  • Kashin-Beck Disease (chemically induced, genetics, physiopathology)
  • Male
  • NF-kappa B (drug effects, genetics)
  • RNA, Long Noncoding (drug effects)
  • Rats
  • Rats, Sprague-Dawley
  • Selenium (blood, toxicity)
  • T-2 Toxin (blood, genetics, toxicity)
  • Tumor Necrosis Factor-alpha (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: